- Home
- CRGX vs AFRI Comparison
CRGX vs AFRI Comparison
Compare CRGX & AFRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRGX
- AFRI
- Stock Information
- Founded
- CRGX 2021
- AFRI 1943
- Country
- CRGX United States
- AFRI Gibraltar
- Employees
- CRGX N/A
- AFRI N/A
- Industry
- CRGX
- AFRI Packaged Foods
- Sector
- CRGX
- AFRI Consumer Staples
- Exchange
- CRGX Nasdaq
- AFRI Nasdaq
- Market Cap
- CRGX 207.5M
- AFRI 207.7M
- IPO Year
- CRGX 2023
- AFRI N/A
- Fundamental
- Price
- CRGX $4.54
- AFRI $7.89
- Analyst Decision
- CRGX Hold
- AFRI
- Analyst Count
- CRGX 7
- AFRI 0
- Target Price
- CRGX $5.33
- AFRI N/A
- AVG Volume (30 Days)
- CRGX 1.7M
- AFRI 10.9K
- Earning Date
- CRGX 08-06-2025
- AFRI 08-29-2025
- Dividend Yield
- CRGX N/A
- AFRI N/A
- EPS Growth
- CRGX N/A
- AFRI N/A
- EPS
- CRGX N/A
- AFRI N/A
- Revenue
- CRGX N/A
- AFRI $274,223,000.00
- Revenue This Year
- CRGX N/A
- AFRI N/A
- Revenue Next Year
- CRGX N/A
- AFRI N/A
- P/E Ratio
- CRGX N/A
- AFRI N/A
- Revenue Growth
- CRGX N/A
- AFRI N/A
- 52 Week Low
- CRGX $3.00
- AFRI $7.47
- 52 Week High
- CRGX $25.45
- AFRI $11.80
- Technical
- Relative Strength Index (RSI)
- CRGX 59.56
- AFRI 58.04
- Support Level
- CRGX $4.45
- AFRI $7.70
- Resistance Level
- CRGX $4.51
- AFRI $8.06
- Average True Range (ATR)
- CRGX 0.04
- AFRI 0.20
- MACD
- CRGX -0.00
- AFRI 0.02
- Stochastic Oscillator
- CRGX 76.00
- AFRI 71.19
About CRGX CARGO Therapeutics Inc.
Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. It programs, platforms, and manufacturing are designed to directly address the limitations of approved chimeric antigen receptor (CAR) T-cell therapies. Its product includes CRG-023, an investigational tri-specific CAR T designed to address several known causes of relapse associated with existing CAR T-cell therapies such as loss of tumor antigen expression, loss of co-stimulation (e.g., via CD58/CD2 signaling) and T cell exhaustion. CRG-023 is designed to target the B-cell lineage antigens (CD19, CD20, CD22) via tri-cistronic expression of three distinct CARs from a single lentiviral vector.
About AFRI Forafric Global PLC
Forafric Global PLC is engaged in production and sale of a variety of wheat flours, Semolina and Pasta and Couscous in Morocco and in more than 45 countries. The two main brands in Morocco are MAYMOUNA and TRIA. The company derives majority of its revenue from Soft wheat.